GENE ONLINE|News &
Opinion
Blog

2025-11-30|

Study Explores Impact of TMS Coil Designs on Phosphene Thresholds and Cortical Excitability

by GOAI
Share To

A recent study published in *BMC Neuroscience* examined the relationship between different types of transcranial magnetic stimulation (TMS) coils and their impact on phosphene thresholds, which serve as a measure of motor cortex excitability. The research, conducted by Fidancı, Alaydın, Cöddü, and their team, focused on how variations in coil design influence the brain’s response to TMS.

The study provides detailed insights into the role of TMS coil configurations in determining phosphene thresholds. Phosphene thresholds are used to assess cortical excitability by measuring the minimum stimulation intensity required to induce visual sensations known as phosphenes. The findings highlight how specific coil designs may affect this threshold differently, offering valuable data for further exploration into TMS applications. Researchers suggest that understanding these differences could have implications for both clinical and experimental uses of TMS technology.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top